ArticlePlastic and reconstructive surgery. Global open2026
The Use of Neoadjuvant Systemic Therapy to Facilitate Nipple-sparing Mastectomy and Immediate Reconstruction.
Article in Plastic and reconstructive surgery. Global open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Neoadjuvant systemic therapy (NST) is a well-established strategy to convert patients initially requiring a mastectomy to breast-conserving surgery, but has not been studied for its efficacy in facilitating total skin-sparing mastectomy (TSSM) and reconstruction in patients with tumors that encroach on the skin- and/or nipple-areola complex (NAC). Methods: The author reviewed his experience from August 2010 through July 2024 with the use of NST to facilitate TSSM and the immediate implant-based reconstruction in patients who were initially not candidates for this approach because of tumor encroachment on the NAC and/or skin envelope. Results: Between 2010 and 2024, the author identified 1425 patients who underwent TSSM with immediate implant reconstructions in his surgical practice. Of these, 160 patients initially presented with disease that precluded preservation of the skin and/or NAC and underwent NST, allowing for TSSM and immediate reconstruction in 138 (86.3%) patients. Conclusions: The use of NST in patients with tumors that encroach on the NAC and/or skin envelope can be used to facilitate TSSM and reconstruction in patients who otherwise would not be candidates for this approach. Reconstructive surgeons should familiarize themselves with the principles of and indications for NST and play an active role in the multidisciplinary treatment planning of these complex patients.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.